Genomics

Dataset Information

35

A low dose of Δ9-THC improves cognitive functions and synaptogenesis in old mice through an epigenetic mechanism


ABSTRACT: THC, the active ingredient of cannabis has been reported to impair learning and memory in humans and in laboratory animals when administered acutely. Unfortunately, most studies have been performed with young individuals although the activity of the endocannabinoid system changes during the aging process. Here we report that low doses of Δ9-THC (Delta-9-Tetrahydrocannabinol) improves learning and memory in old mice, enhances synaptic density, increases the expression of anti-ageing genes and decreases expression of pro-ageing genes in old but not in young animals. Δ9-THC elicited its beneficial effect through the CB1 receptors and increased histone acetylation was crucial for the long lasting effect. Elevation of the cannabinoid signaling may thus represent an exciting new approach to improve brain functions in old individuals. Overall design: Three-five male 2- and 12-month-old C57BL/6J mice were chronically treated with 3 mg/kg/day Δ9-tetrahydrocannabinol through subcutaneously implanted osmotic minipump (Alzet, Cupertino, CA, model 1004, delivery speed: 0.11 µl/h) for 28 days. Control animals received vehicle (ethanol: cremophor: saline 1:1:18). Five days after termination of drug treatment the animals were tested in water-mate test (between day 33 and 41). Animals were sacrificed 5 days after the behavioural tests (day 46) by CO2 inhalation, decapitated and their hippocampi were isolated. The hippocampi were snap frozen in dry ice cooled isopentane and stored at -80C until further processing.

INSTRUMENT(S): Illumina MouseWG-6 v2.0 expression beadchip

SUBMITTER: Joachim Schultze  

PROVIDER: GSE57823 | GEO | 2017-05-08

SECONDARY ACCESSION(S): PRJNA248276

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
GSE57823_RAW.tar Raw
GSE57823_non_normalized.txt.gz Txt
filelist.txt Txt
Items per page:
1 - 3 of 3
altmetric image

Publications


The balance between detrimental, pro-aging, often stochastic processes and counteracting homeostatic mechanisms largely determines the progression of aging. There is substantial evidence suggesting that the endocannabinoid system (ECS) is part of the latter system because it modulates the physiological processes underlying aging. The activity of the ECS declines during aging, as CB1 receptor expression and coupling to G proteins are reduced in the brain tissues of older animals and the levels of  ...[more]

Similar Datasets

2018-12-31 | GSE116813 | GEO
2018-01-01 | S-EPMC6097764 | BioStudies
2015-01-01 | S-EPMC4300675 | BioStudies
2016-01-22 | GSE72766 | GEO
2019-01-01 | S-EPMC6784991 | BioStudies
2019-01-01 | S-EPMC6600594 | BioStudies
2019-01-01 | S-EPMC6590252 | BioStudies
2020-01-01 | S-EPMC7688511 | BioStudies
2014-11-19 | E-GEOD-61654 | ArrayExpress
2017-01-01 | S-EPMC5238805 | BioStudies